Why Merck's $6.7 Billion Deal Could Start A Fight
Merck made plans Wednesday to beef up its cancer treatment portfolio with the acquisition of Terns Pharma.

Source: Investor's Business Daily
Merck made plans Wednesday to beef up its cancer treatment portfolio with the acquisition of Terns Pharma.